Importing Outside Images to PACS Significantly Cuts Repeat Imaging

Article

Patients whose outside images were imported into their institutions' PACS were significantly less likely to undergo repeat imaging.

Importing outside images to the PACS reduces the rate of repeat imaging tests, lowering patient costs and exposure to radiation, according to a study published in the March issue ofAmerican Journal of Roentgenology.

Researchers from the University of California in San Francisco undertook a retrospective study looking at 267 patients who had undergone an abdominal CT or MRI scan at their institution or at another within four months before undergoing transarterial chemoembolization.

The researchers were looking at the availability of images from the other institutions to their institutions. They examined whether the images were on CD or film but not imported, which images were imported, and if no outside imaging was available at all.

Researchers found:

• If the patients’ outside images were not available, 72 percent of the patients had repeat imaging.
• If the patients’ outside images were available but not imported to the PACS, 52 percent had repeat imaging.
• If the patients’ outside images were imported to the PACS, 11 percent had repeat imaging.
• If the imaging was done at their institution, 13 percent of patients had repeat imaging.

“Patients whose outside images were imported were significantly less likely to undergo repeat imaging than were both the groups whose outside images were not imported,” the authors wrote.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.